Sustained and Complete Phenotype Correction of Hemophilia B Mice Following Intramuscular Injection of AAV1 Serotype Vectors

This publication has 27 references indexed in Scilit:

• Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA
  Blood, 2001
• Several Log Increase in Therapeutic Transgene Delivery by Distinct Adeno-Associated Viral Serotype Vectors
  Molecular Therapy, 2000
• Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
  Nature Genetics, 2000
• The Use of Adeno-Associated Virus to Circumvent the Maturation-Dependent Viral Transduction of Muscle Fibers
  Human Gene Therapy, 2000
• Persistent expression of canine factor IX in hemophilia B canines
  Gene Therapy, 1999
• Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector
  Nature Medicine, 1999
• Human Factor IX Corrects the Bleeding Diathesis of Mice With Hemophilia B
  Blood, 1998
• Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus
  Proceedings of the National Academy of Sciences, 1997
• Haemophilia prophylaxis in young patients–a long‐term follow‐up
  Journal of Internal Medicine, 1997
• Adeno-associated Viral Vectors
  Published by Springer Nature ,1995